Faes Farma, S.A. (BME:FAE)

Market Cap	1.62B +49.6%
Revenue (ttm)	571.12M +13.3%
Net Income	105.08M +7.7%
EPS	0.34
Shares Out	311.26M
PE Ratio	15.48
Forward PE	18.48
Dividend	0.16 (3.01%)
Ex-Dividend Date	Jan 8, 2026

Volume	23,096
Average Volume	148,124
Open	5.20
Previous Close	5.22
Day's Range	5.15 - 5.21
52-Week Range	3.27 - 5.44
Beta	0.25
RSI	57.38
Earnings Date	Feb 26, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1933
• Employees: 1,894
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: FAE

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.